Cargando…
Modified Suanzaorentang Had the Treatment Effect for Generalized Anxiety Disorder for the First 4 Weeks of Paroxetine Medication: A Pragmatic Randomized Controlled Study
Background. Paroxetine does not show satisfactory therapeutic effect for generalized anxiety disorder (GAD) patients for the first 2–4 weeks of medication. Diazepam is always concurrently used although it has some shortcomings such as physical dependence and withdrawal reactions. In this study, we a...
Autores principales: | Song, Ming-Fen, Hu, Lin-Lin, Liu, Wen-Juan, Liu, Yi, Tao, Xiao-Yun, Wang, Ting-Ting, Wang, Sheng-Dong, Zhang, Long, Zhang, Yong-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434311/ https://www.ncbi.nlm.nih.gov/pubmed/28553362 http://dx.doi.org/10.1155/2017/8391637 |
Ejemplares similares
-
Efficacy of cognitive behavioral therapy with paroxetine and paroxetine only for social anxiety disorder: A behavioral, placebo-controlled study
por: Samantray, Narendranath, et al.
Publicado: (2019) -
Paroxetine overdose
por: Gupta, Arun K., et al.
Publicado: (2005) -
Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients
por: Li, Xiao-lin, et al.
Publicado: (2022) -
Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats
por: Hernández-Arrambide, Pedro Efraín, et al.
Publicado: (2022) -
Paroxetine and Mortality in Heart Failure: A Retrospective Cohort Study
por: Xu, Hongxuan, et al.
Publicado: (2022)